#AQCH

[rnewsworldenglish]

Sun Pharma initiates Phase-II clinical trial on AQCH for treatment of COVID-19 patients

Sun Pharma initiates Phase-II clinical trial on AQCH for treatment of COVID-19 patients

Solar Pharmaceutical Industries Ltd. which incorporates its subsidiaries and/or affiliate corporations has commenced Part-II scientific trial on AQCH, a phytopharmaceutical (plant-derived) drug for remedy for COVID-19.

The corporate had acquired approval from the Medication Controller Normal of India (DCGI) for conducting Part-II scientific trial in April this yr.

The scientific trial might…

[gostcoder]

सन फार्मा टेस्टिंग प्लांट-आधारित ड्रग AQCH को संभावित कोविद -19 उपचार के रूप में

सन फार्मा टेस्टिंग प्लांट-आधारित ड्रग AQCH को संभावित कोविद -19 उपचार के रूप में

[ad_1]

प्रतिनिधित्व के लिए छवि। (छवि: रायटर)

AQCH उष्णकटिबंधीय, कोकबुलस हिरसुतस पर चढ़ने से प्राप्त होता है, जिसका उपयोग एशिया में इसके स्पष्ट औषधीय गुणों के लिए किया जाता है।

रायटर बेंगलुरु

आखरी अपडेट: 5 जून, 2020, 12:56 PM IST

भारतीय दवा निर्माता सन फार्मास्युटिकल इंडस्ट्रीज लिमिटेड ने शुक्रवार को कहा कि यह एक मिड-स्टेज ट्रायल के हिस्से के रूप में COVID-19 के संभावित उपचार के लिए…

[newscountryindia]

COVID-19 Crisis: Sun Pharma Testing Plant-Based Drug As Potential Treatment Sun Pharma received approval from regulator DCGI for the AQCH trial in April, data showed Bengaluru: …

[news24fresh]

Sun Pharma initiates Phase-II clinical trial on AQCH for treatment of COVID-19 patients

Sun Pharma initiates Phase-II clinical trial on AQCH for treatment of COVID-19 patients

[ad_1]

Sun Pharmaceutical Industries Ltd. which includes its subsidiaries and/or associate companies has commenced Phase-II clinical trial on AQCH, a phytopharmaceutical (plant-derived) drug for treatment for COVID-19.

The company had received approval from the Drugs Controller General of India (DCGI) for conducting Phase-II clinical trial in April this year.

The clinical trial will be…

[biotecnika]

Dengue Drug To Treat COVID-19 Enters Phase II Clinical Trial The Phase II clinical trials of Sun Pharma’s AQCH, a plant-derived drug for the treatment of COVID-19, has been commenced. The Drugs Controller General of India (DCGI) approved the Sun Pharma for conducting the Phase II clinical trial in April. The council of Scientific and […] The post Dengue Drug AQCH To Treat COVID-19 Enters Phase II Clinical Trial appeared first on BioTecNika .

[indianfitnesscare]

Scientists Develop Anti-viral Drug to Treat Dengue

Scientists Develop Anti-viral Drug to Treat Dengue

Derived from plants, AQCH, is anti-viral in nature. It was tested successfully in labs and on mice. Trials will be conducted at one medical college in Kanpur, Lucknow, Agra, Mumbai, Thane, Pune, Aurangabad, Ahmedabad, Kolkata, Bengaluru, Mangalore, Belgaum, Chennai, Jaipur, Chandigarh, Visakahapatnam, Cuttack, Khurda and Nathdwara. At each centre, a total of 100 patients will receive this…

[pantherwriterblogger]

Find out the answer for What is aqch drug? at #AskSawal Ask Sawal is a question answer discussion forum. You can find answers for more than 2 billion questions targetting more than 50000 topics.

[laurasgroi]

Last week was extremely hard. Painful. Still hurts. While I am still grieving and will be for a while, I commit to keep informing and educating myself, learning, unlearning, accepting, digesting history and current information, I am grateful for this awakening and grateful for my family and friends who shed light in this process. I won't let the pain and doubt paralyze me as it has happened before. I have received the reminders that there is no point in having a voice if I don't use it for the causes that need it. I will speak more and louder on #visibility and #representation. I owe this to myself, to my son, the people of my country and to the world. #Kindness and #compassion always above all. https://www.instagram.com/p/CBOSPq-AQCH/?igshid=18ajp3wxc55ff

[dailynewsupdatesindia]

Coronavirus treatment: Sun Pharma testing plant-based drug as potential Covid-19 medicine "AQCH, which is being developed for dengue, has shown broad antiviral effect in in-vitro studies and hence is being tested as a potential treatment option for coronavirus," the company said in a statement.

[huffplatform]

Coronavirus treatment: Sun Pharma testing plant-based drug as potential Covid-19 medicine - India Today

"AQCH, which is being developed for dengue, has shown broad antiviral effect in in-vitro studies and hence is being tested as a potential treatment option for coronavirus," the company said in a statement. Indian drugmaker Sun Pharmaceutical Industries Ltd said on Friday it was testing a plant-derived drug, AQCH, for the potential treatment of COVID-19 as part of a mid-stage trial, with results expected by October. AQCH is derived from tropical, climbing shrub cocculus hirsutus, which is used in Asia for its apparent medicinal properties. The company said the trial will be conducted across 12 centers in India in 210 patients  . . Continue Reading… or, Direct Website Link: https://www.indiatoday.in/world/story/coronavirus-treatment-sun-pharma-plant-based-drug-covid19-medicine-1685818-2020-06-05 News published on: India Today Read the full article

[rnewsworldenglish]

Sun Pharma Testing Plant-based Drug AQCH as Potential Covid-19 Treatment

Sun Pharma Testing Plant-based Drug AQCH as Potential Covid-19 Treatment

Picture for illustration. (Picture: Reuters)

AQCH is derived from tropical, climbing shrub cocculus hirsutus, which is utilized in Asia for its obvious medicinal properties.

Reuters Bengaluru

Final Up to date: June 5, 2020, 12:56 PM IST

Indian drugmaker Solar Pharmaceutical Industries Ltd stated on Friday it was testing a plant-derived drug, AQCH, for the potential…

[biotechtimes]

Dengue drug enters Phase II clinical trial for COVID-19

New Post has been published on https://biotechtimes.org/2020/06/05/dengue-drug-enters-phase-ii-clinical-trial-for-covid-19/

Dengue drug enters Phase II clinical trial for COVID-19

By Jyoti Singh

New Delhi, 05 June: Sun Pharma has announced that it has commenced Phase II clinical trial on AQCH, a phytopharmaceutical (plant-derived) drug for the treatment of COVID-19. The company received approval from the Drugs Controller General of India (DCGI) for conducting the Phase II clinical trial in April this year. The research is being done in association with the Council of Scientific and Industrial Research (CSIR) and Department of Biotechnology (DBT).

The clinical trial will be conducted across 12 centres in 210 patients located in Delhi, Mumbai, Ahmedabad, and other places spread across the country. The treatment duration for patients will be 10 days. The results of the clinical trial are expected by October 2020. The human safety study of AQCH has already been completed and the drug has been found safe at the recommended dose for Phase II study.

Since 2016, Sun Pharma has been working closely with DBT-International Centre for Genetic Engineering and Biotechnology (ICGEB), under the leadership of Dr. Navin Khanna, and CSIR-Indian Institute of Integrative Medicine (IIIM), Jammu, under the leadership of Dr. Ram Vishwakarma, to develop a phytopharmaceutical drug for dengue.

Dilip Shanghvi, Managing Director, Sun Pharma said, “This is the first phytopharmaceutical drug approved for clinical trials by the DCGI as a potential treatment for COVID-19. AQCH has shown anti-SARS-CoV-2 effects in in-vitro studies conducted in collaboration with ICGEB, Italy. These results, combined with information on the mechanism of action through in-vitro and small animal studies, give us the confidence to evaluate this potential treatment option for COVID-19 patients.”

“Preclinical development and IND enabling (Investigational New Drug Application) studies have been done by IIIM Jammu. After that, Sun Pharma carried out IND submission and clinical trial work. This is a perfect example of synergy among public institutions, R&D organisations, and private companies,” said Dr. Ram Vishwakarma, Director, IIIM Jammu.

AQCH, which is being developed for dengue, has shown a broad antiviral effect in in vitro studies and hence is being tested as a potential treatment option for COVID-19.

The work on the evaluation of plant-derived drugs for the treatment of dengue started in 2007 under the auspices of the DBT Task Force on Medicinal and Aromatic Plants.

Dr. Renu Swarup, Secretary, DBT, stated: “Our efforts to develop a safe, effective and affordable drug against dengue started about 13 years ago. The collaborating team quickly initiated studies for the development of a drug against COVID-19. I wish the collaborating team success in the conduct of the clinical trial against COVID-19 and for the development of phytopharmaceutical drugs against other infectious diseases.”

Dr. Shekhar C Mande, Director General, CSIR, commented that “CSIR has had a long-standing association with the pharmaceutical industry in India and welcomes this collaboration with Sun Pharma in taking forward AQCH into clinical trials for COVID-19 patients. This collaboration aligns with our scientific rationale for the quickest way to develop drugs against SARS-CoV-2”. (India Science Wire)

[news24fresh]

Sun initiates phase II trial of COVID-19 drug

Sun initiates phase II trial of COVID-19 drug

[ad_1]

Sun Pharmaceutical Industries Ltd. which includes its subsidiaries and/or associate companies has commenced the phase II clinical trial on AQCH, a phytopharmaceutical (plant-derived) drug for the treatment of COVID-19.

The company had received approval from the Drugs Controller General of India (DCGI) for conducting the phase II clinical trial in April this year.

The clinical trial…

[beardedpuppymoon]

Coronavirus remedy: Solar Pharma testing plant-based drug as potential Covid-19 medication https://www.today-24.com/coronavirus-remedy-solar-pharma-testing-plant-based-drug-as-potential-covid-19-medication/?feed_id=15318&_unique_id=5eda2b4d2c707 "AQCH, which is being developed for d...

[popularnews]

Sun Pharma Testing Plant-Based Drug AQCH As Potential COVID-19 Treatment

[newscountryindia]

Coronavirus treatment: Sun Pharma testing plant-based drug as potential Covid-19 medicine "AQCH, which is being developed for dengue, has shown broad antiviral effect in in-vitro studies and hence is being tested as a potential treatment option for coronavirus," the company said in a statement.